RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
KeyMed Biosciences - Stock

KeyMed Biosciences Debt 2024

KeyMed Biosciences Debt

-432.32 CNY

Ticker

2162.HK

ISIN

KYG5252B1023

WKN

A3CTJD

In 2024, KeyMed Biosciences's total debt was -432.32 CNY, a -10.33% change from the -482.1 CNY total debt recorded in the previous year.

KeyMed Biosciences Aktienanalyse

What does KeyMed Biosciences do?

KeyMed Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding KeyMed Biosciences's Debt Structure

KeyMed Biosciences's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing KeyMed Biosciences's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to KeyMed Biosciences’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in KeyMed Biosciences’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about KeyMed Biosciences Stock

What is the debt of KeyMed Biosciences this year?

KeyMed Biosciences has a debt level of -432.32 CNY this year.

What was the debt of KeyMed Biosciences compared to the previous year?

The debt of KeyMed Biosciences has increased by -10.33% compared to the previous year dropped.

What are the consequences of high debt for investors in KeyMed Biosciences?

High debt can pose a risk for investors of KeyMed Biosciences, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of KeyMed Biosciences?

Low debt means that KeyMed Biosciences has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from KeyMed Biosciences affect the company?

An increase in debt of KeyMed Biosciences can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of KeyMed Biosciences affect the company?

A reduction in debt of KeyMed Biosciences can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of KeyMed Biosciences?

Some factors that can influence the debt of KeyMed Biosciences include investments, acquisitions, operating costs, and revenue development.

Why are the debts of KeyMed Biosciences so important for investors?

The debts of KeyMed Biosciences are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can KeyMed Biosciences take to change the debt?

To change the debt, KeyMed Biosciences can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does KeyMed Biosciences pay?

Over the past 12 months, KeyMed Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, KeyMed Biosciences is expected to pay a dividend of 0 CNY.

What is the dividend yield of KeyMed Biosciences?

The current dividend yield of KeyMed Biosciences is .

When does KeyMed Biosciences pay dividends?

KeyMed Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of KeyMed Biosciences?

KeyMed Biosciences paid dividends every year for the past 0 years.

What is the dividend of KeyMed Biosciences?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is KeyMed Biosciences located?

KeyMed Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von KeyMed Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of KeyMed Biosciences from 6/17/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 6/17/2024.

When did KeyMed Biosciences pay the last dividend?

The last dividend was paid out on 6/17/2024.

What was the dividend of KeyMed Biosciences in the year 2023?

In the year 2023, KeyMed Biosciences distributed 0 CNY as dividends.

In which currency does KeyMed Biosciences pay out the dividend?

The dividends of KeyMed Biosciences are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von KeyMed Biosciences

Our stock analysis for KeyMed Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of KeyMed Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.